PHP
TMCI icon

Parkman Healthcare Partners’s Treace Medical Concepts TMCI Stock Holding History

Parkman Healthcare Partners’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-199,393
Closed -$489K – 112
2025
Q4 		$489K Sell
199,393
-648,282
-76% -$2.82M 0.05% 98
2025
Q3 		$5.69M Buy
847,675
+3,677
+0.4% +$24K 0.59% 61
2025
Q2 		$4.96M Buy
843,998
+130,459
+18% +$850K 0.57% 61
2025
Q1 		$5.99M Buy
+713,539
New +$6.41M 0.71% 46

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkman Healthcare Partners's TMCI Position: Q1 2026 in Review

Parkman Healthcare Partners sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 199,393 shares — an estimated $489K sold.

Parkman Healthcare Partners first reported a position in TMCI in Q1 2025 and held it in 4 quarters. The position peaked at $5.99M in Q1 2025. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Parkman Healthcare Partners reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Parkman Healthcare Partners sold 199,393 Treace Medical Concepts shares in Q1 2026, an estimated $489K.
  • Parkman Healthcare Partners first reported a position in Treace Medical Concepts in Q1 2025 and held it in 4 quarters.
  • Parkman Healthcare Partners's Treace Medical Concepts position peaked at $5.99M in Q1 2025.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.